Aro-Aat, A Subcutaneous Rnai-Based Therapeutic For Alpha-1 Antitrypsin-Related Liver Disease, Demonstrates Liver Exposure-Response And Efficacy In Preclinical StudiesC. Wooddell,K. Blomenkamp, H. Chen,J. Griffin,R. Zhu, Q. Chu,H. Hamilton,J. Hegge, D. Christianson,Z. Li,J. Teckman,B. GivenJOURNAL OF HEPATOLOGY（2018）引用 6|浏览20暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
